GLP-3 RT 30mg Peptides
Precision starts with a peptide you can trust.
Primavora GLP-3 RT is a single-ingredient research peptide presented as a lyophilized vial for controlled laboratory use. This unflavored, dry-format preparation is designed for investigators who require consistent lot-to-lot performance and clear documentation. Each vial provides a total content of 30mg, delivering a straightforward basis for concentration planning and protocol standardization.
- Each vial contains 30mg of GLP-3 RT, supporting reproducible method development, peptide-pathway exploration, and assay optimization where consistency and accurate dilution are critical.
As a lyophilized preparation, GLP-3 RT is engineered for reliable handling and dependable performance in research settings. Investigators value the stable, dry format for precise volumetric planning and controlled reconstitution with a suitable laboratory-grade diluent. The resulting solution is intended for measured aliquoting, minimizing freeze-thaw exposure and supporting consistent application across parallel experiments and iterative study designs.
This vial is prepared to align with rigorous laboratory expectations. Batches are produced in the USA under cGMP principles, then qualified through high-performance liquid chromatography and mass spectrometry to verify identity and assess purity. Each lot is released with documentation to support traceability and review. Careful lyophilization and controlled handling help preserve integrity through packaging and shipment, with tamper-evident measures for added confidence upon receipt.
Primavora emphasizes exacting standards at every step—sourcing, processing, testing, and packaging—to help researchers maintain clarity in their data and confidence in their materials. From consistent composition to dependable documentation, this GLP-3 RT vial reflects a disciplined approach to peptide quality. For additional transparency, lot-specific certificates are available to support your internal quality systems and recordkeeping needs.
Research Use Only. Not for human consumption or injection. Not for clinical, therapeutic, or veterinary use. Handle using appropriate laboratory practices and personal protective equipment consistent with your institution’s guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
